Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers
- 1 April 2009
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (4) , 1686-1689
- https://doi.org/10.1128/aac.01467-08
Abstract
The antifungal susceptibility profiles of 77 clinical strains of Mucorales species, identified by internal transcribed spacer sequencing, were analyzed. MICs obtained at 24 and 48 h were compared. Amphotericin B was the most active agent against all isolates, except for Cunninghamella and Apophysomyces isolates. Posaconazole also showed good activity for all species but Cunninghamella bertholletiae . Voriconazole had no activity against any of the fungi tested. Terbinafine showed good activity, except for Rhizopus oryzae , Mucor circinelloides , and Rhizomucor variabilis isolates.Keywords
This publication has 28 references indexed in Scilit:
- Posaconazole Enhances the Activity of Amphotericin B against Hyphae of Zygomycetes In VitroAntimicrobial Agents and Chemotherapy, 2008
- Time of Incubation for Antifungal Susceptibility Testing of Aspergillus fumigatus : Can MIC Values Be Obtained at 24 Hours?Antimicrobial Agents and Chemotherapy, 2007
- In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2007
- Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infectionsTransplant Infectious Disease, 2007
- Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapyBone Marrow Transplantation, 2007
- Prevalence and Susceptibility Testing of New Species of Pseudallescheria and Scedosporium in a Collection of Clinical Mold IsolatesAntimicrobial Agents and Chemotherapy, 2007
- In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38‐A microdilution methodMycoses, 2005
- Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent CasesThe Journal of Infectious Diseases, 2005
- Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving VoriconazoleClinical Infectious Diseases, 2004
- Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of ZygomycosisAntimicrobial Agents and Chemotherapy, 2002